James M Ahlers insider trades
Open-market stock purchases and sales by James M Ahlers, Chief Financial Officer at Cue Biopharma, Inc, from SEC Form 4 filings since Jul 30, 2026.
Companies traded
- CUE Cue Biopharma, Inc: other filings, last Jul 30, 2026